# Rituximab Exhibits a Long Half-Life Based on a Population Pharmacokinetic Analysis in Non-Hodgkin’s Lymphoma (NHL) Patients.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rituximab-exhibits-a-long-half-life-based-on-a-population-pharmacokinetic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jing Li,Micha Levi,Jean‐Eric Charoin,Nicolas Frey,Thian Kheoh,Song Ren,Michael Woo,Amita Joshi,Nancy Valente,Nelson “Shasha” Jumbe |
| Citations | 30 |
| DOI | 10.1182/blood.v110.11.2371.2371 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2980786352 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Song Ren](https://scholariq.org/researchers/song-ren/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Paper topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.